{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T10:12:46Z","timestamp":1775470366903,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008353","name":"Funda\u00e7\u00e3o de Apoio ao Ensino, Pesquisa e Assist\u00eancia do Hospital das Cl\u00ednicas da Faculdade de Medicina de Ribeir\u00e3o Preto da Universidade de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["305299\/2018"],"award-info":[{"award-number":["305299\/2018"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["GR004596"],"award-info":[{"award-number":["GR004596"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Intra-arterial chemotherapy (IAC) has been used to treat multiple cancers including liver metastasis from uveal and cutaneous melanoma but not as primary tumor treatment. We report the compassionate use of chemoreduction with intra-arterial melphalan before ruthenium brachytherapy to salvage an eye with choroidal melanoma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 61-year-old female patient complained of decreased vision and central-temporal scotoma in OS (left eye) for 1\u00a0month. Visual acuity was 20\/20 in right eye (OD) and 20\/125 OS. Anterior segment examination and intraocular pressure were unremarkable in both eyes, as was fundus examination of the OD. Fundus examination of OS revealed a brown, solid tumor partially obscuring the temporal optic disc margin and extending to the equatorial fundus midzone. Serous retinal detachment was present over the lesion and around it. Ultrasonography revealed a solid choroidal tumor with a largest basal diameter (LBD) of 13.0\u00a0mm and thickness of 10.4\u00a0mm. The tumor presented acoustic hollowness and a superimposing retinal detachment. After metastatic screening was negative, the patient underwent intra-arterial chemotherapy with melphalan. Three weeks later, her visual acuity was 20\/200 and there was noticeable tumor regression to 11.9\u00a0mm (LBD) by 7.9\u00a0mm (thickness) allowing brachytherapy to be performed. Ten weeks after brachytherapy (13\u00a0weeks after IAC), visual acuity was HM due to biopsy-related vitreous hemorrhage (VH). Tumor dimensions were 9.9 (LBD) mm and 6.5\u00a0mm (thickness) and PPV was performed to remove VH. Six weeks after PPV (20\u00a0weeks after IAC), her visual acuity was 20\/200 and further reduction of tumor dimensions was observed: largest basal diameter was 8.9\u00a0mm and thickness was 4.9\u00a0mm.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This case illustrates the feasibility of combining induction IAC prior to ruthenium brachytherapy for large choroidal melanoma. More studies are warranted to confirm these early preliminary findings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40942-022-00404-1","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T12:02:54Z","timestamp":1660737774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Melphalan intra-arterial chemotherapy for choroidal melanoma chemoreduction"],"prefix":"10.1186","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2652-0720","authenticated-orcid":false,"given":"Rodrigo","family":"Jorge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Viani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda Alexia R.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Chahud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel G.","family":"Abud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zelia M.","family":"Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"key":"404_CR1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S89591","author":"BA Krantz","year":"2017","unstructured":"Krantz BA, Dave N, Komatsubara KM, Marr BP, Carvajal RD. Uveal melanoma: epidemiology, etiology, and treatment of primary disease. Clin Ophthalmology. 2017. https:\/\/doi.org\/10.2147\/OPTH.S89591.","journal-title":"Clin Ophthalmology"},{"issue":"1","key":"404_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40487-018-0056-8","volume":"6","author":"M Singh","year":"2018","unstructured":"Singh M, Durairaj P, Yeung J. Uveal melanoma: a review of the literature. Oncol Ther. 2018;6(1):87\u2013104. https:\/\/doi.org\/10.1007\/s40487-018-0056-8.","journal-title":"Oncol Ther"},{"key":"404_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brachy.2013.11.008","volume":"13","author":"The American Brachytherapy Society\u2014Ophthalmic Oncology Task Force","year":"2014","unstructured":"The American Brachytherapy Society\u2014Ophthalmic Oncology Task Force. The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma. Brachytherapy. 2014;13:1\u201314. https:\/\/doi.org\/10.1016\/j.brachy.2013.11.008.","journal-title":"Brachytherapy"},{"key":"404_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000761","author":"DA Reichstein","year":"2021","unstructured":"Reichstein DA, Brock AL. Radiation therapy for uveal melanoma: a review of treatment methods available in 2021. Curr Opin Ophthalmol. 2021. https:\/\/doi.org\/10.1097\/ICU.0000000000000761.","journal-title":"Curr Opin Ophthalmol"},{"key":"404_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30459-9","author":"T Parker","year":"2020","unstructured":"Parker T, Rigney G, Kallos J, Stefko ST, Kano H, Niranjan A, et al. Gamma knife radiosurgery for uveal melanomas and metastases: a systematic review and meta-analysis. Lancet Oncol. 2020. https:\/\/doi.org\/10.1016\/S1470-2045(20)30459-9.","journal-title":"Lancet Oncol"},{"issue":"24","key":"404_CR6","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.3390\/cancers13246241","volume":"13","author":"M Marinkovic","year":"2021","unstructured":"Marinkovic M, Pors LJ, van den Berg V, Peters FP, Schalenbourg A, Zografos L, Pica A, Hrbacek J, Van Duinen SG, Vu THK, Bleeker JC, Rasch CRN, Jager MJ, Luyten GPM, Horeweg N. Clinical outcomes after international referral of uveal melanoma patients for proton therapy. Cancers (Basel). 2021;13(24):6241. https:\/\/doi.org\/10.3390\/cancers13246241.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"404_CR7","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3390\/cancers14051194","volume":"14","author":"J Thariat","year":"2022","unstructured":"Thariat J, Martel A, Matet A, Loria O, Kodjikian L, Nguyen AM, Rosier L, Herault J, Nahon-Est\u00e8ve S, Mathis T. Non-cancer effects following ionizing irradiation involving the eye and orbit. Cancers (Basel). 2022;14(5):1194. https:\/\/doi.org\/10.3390\/cancers14051194.","journal-title":"Cancers (Basel)"},{"key":"404_CR8","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/00000658-195810000-00009","volume":"148","author":"O Creech","year":"1958","unstructured":"Creech O, Krementz ET, Ryan RF, Winblad JN. Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg. 1958;148:616\u201332. https:\/\/doi.org\/10.1097\/00000658-195810000-00009.","journal-title":"Ann Surg"},{"key":"404_CR9","first-page":"2631","volume":"47","author":"J Hansson","year":"1987","unstructured":"Hansson J, Lewensohn R, Ringborg U, Nilsson B. Formation and removal of DNA cross-links induced by melphalan and nitrogen mustard in relation to drug-induced cytotoxicity in human melanoma cells. Cancer Res. 1987;47:2631\u20137.","journal-title":"Cancer Res"},{"issue":"11","key":"404_CR10","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1002\/1097-0142(19850601)55:11<2638::aid-cncr2820551118>3.0.co;2-e","volume":"55","author":"DR Minor","year":"1985","unstructured":"Minor DR, Allen RE, Alberts D, Peng YM, Tardelli G, Hutchinson J. A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma. Cancer. 1985;55(11):2638\u201344. https:\/\/doi.org\/10.1002\/1097-0142(19850601)55:11%3c2638::aid-cncr2820551118%3e3.0.co;2-e.","journal-title":"Cancer"},{"key":"404_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/APO.0000000000000172","author":"CL Shields","year":"2016","unstructured":"Shields CL, Jorge R, Say EA, Magrath G, Alset A, Caywood E, et al. Unilateral retinoblastoma managed with intravenous chemotherapy versus intra-arterial chemotherapy. Outcomes based on the international classification of retinoblastoma. Asia Pac J Ophthalmol (Phila). 2016. https:\/\/doi.org\/10.1097\/APO.0000000000000172.","journal-title":"Asia Pac J Ophthalmol (Phila)."},{"issue":"1","key":"404_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084247","volume":"9","author":"JH Francis","year":"2014","unstructured":"Francis JH, Abramson DH, Gobin YP, Marr BP, Dunkel IJ, Riedel ER, Brodie SE. Electroretinogram monitoring of dose-dependent toxicity after ophthalmic artery chemosurgery in retinoblastoma eyes: six year review. PLoS ONE. 2014;9(1): e84247. https:\/\/doi.org\/10.1371\/journal.pone.0084247.","journal-title":"PLoS ONE"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-022-00404-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-022-00404-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-022-00404-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T12:17:17Z","timestamp":1660738637000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-022-00404-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["404"],"URL":"https:\/\/doi.org\/10.1186\/s40942-022-00404-1","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,17]]},"assertion":[{"value":"24 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient signed an informed consent before off label use of Melphalan IAC for Choroidal Melanoma was performed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None related to the discussed topic.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}